Kovai Medical Cente And Hospital Share Price
Sector: Healthcare Facilities
5843.00 -17.80 (-0.30%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
5805
Today’s High
5898
52 Week Low
3922.05
52 Week High
6400
Key Metrics
- Market Cap (In Cr) 6446.33
- Beta 1.03
- Div. Yield (%) 0.17
- P/B 7.22
- TTM P/E 31.63
- Peg Ratio 0.96
- Sector P/E 22.75
- Open Price 5898
- Prev Close 5860.8
Kovai Medical Cente And Hospital Analysis
Price Analysis
-
1 Week-2.04%
-
3 Months-4.25%
-
6 Month9.84%
-
YTD-1.78%
-
1 Year26.71%
Risk Meter
- 45% Low risk
- 45% Moderate risk
- 45% Balanced Risk
- 45% High risk
- 45% Extreme risk
Kovai Medical Cente And Hospital Financials
- INCOME
- BALANCE SHEET
- Cashflow
- Period
- 2024
- Total Revenue
- 1219.55
- Selling/ General/ Admin Expenses Total
- 523.61
- Depreciation/ Amortization
- 92.14
- Other Operating Expenses Total
- 6.05
- Total Operating Expense
- 969.63
- Operating Income
- 249.92
- Net Income Before Taxes
- 237.56
- Net Income
- 179.73
- Diluted Normalized EPS
- 164.48
- Period
- 2024
- Total Assets
- 1438.23
- Total Liabilities
- 549.7
- Total Equity
- 888.54
- Tangible Book Valueper Share Common Eq
- 810.67
- Period
- 2024
- Cashfrom Operating Activities
- 192.68
- Cashfrom Investing Activities
- -138.17
- Cashfrom Financing Activities
- -243.49
- Net Changein Cash
- -188.99
- Period
- 2023
- Total Revenue
- 1019.75
- Selling/ General/ Admin Expenses Total
- 447.57
- Depreciation/ Amortization
- 89.13
- Other Operating Expenses Total
- 2.2
- Total Operating Expense
- 839.3
- Operating Income
- 180.45
- Net Income Before Taxes
- 155.22
- Net Income
- 115.77
- Diluted Normalized EPS
- 106.5
- Period
- 2023
- Total Assets
- 1438.12
- Total Liabilities
- 719.08
- Total Equity
- 719.04
- Tangible Book Valueper Share Common Eq
- 655.66
- Period
- 2023
- Cashfrom Operating Activities
- 32.27
- Cashfrom Investing Activities
- -126.86
- Cashfrom Financing Activities
- -85.7
- Net Changein Cash
- -180.29
- Period
- 2022
- Total Revenue
- 906
- Selling/ General/ Admin Expenses Total
- 364.02
- Depreciation/ Amortization
- 85.43
- Other Operating Expenses Total
- 12.12
- Total Operating Expense
- 732.96
- Operating Income
- 173.03
- Net Income Before Taxes
- 140.68
- Net Income
- 104.26
- Diluted Normalized EPS
- 95.92
- Period
- 2022
- Total Assets
- 1342.66
- Total Liabilities
- 733.35
- Total Equity
- 609.31
- Tangible Book Valueper Share Common Eq
- 554.53
- Period
- 2022
- Cashfrom Operating Activities
- 69.73
- Cashfrom Investing Activities
- -99.1
- Cashfrom Financing Activities
- -119.77
- Net Changein Cash
- -149.13
- Period
- 2021
- Total Revenue
- 690.36
- Selling/ General/ Admin Expenses Total
- 284.42
- Depreciation/ Amortization
- 68.03
- Other Operating Expenses Total
- 6.47
- Total Operating Expense
- 565.08
- Operating Income
- 125.28
- Net Income Before Taxes
- 105.74
- Net Income
- 77.69
- Diluted Normalized EPS
- 70.89
- Period
- 2021
- Total Assets
- 1280.81
- Total Liabilities
- 770.81
- Total Equity
- 510
- Tangible Book Valueper Share Common Eq
- 463.77
- Period
- 2021
- Cashfrom Operating Activities
- 38.18
- Cashfrom Investing Activities
- -180.48
- Cashfrom Financing Activities
- 38.03
- Net Changein Cash
- -104.27
- Period
- 2020
- Total Revenue
- 711.73
- Selling/ General/ Admin Expenses Total
- 316.98
- Depreciation/ Amortization
- 52.12
- Other Operating Expenses Total
- 6.24
- Total Operating Expense
- 594.49
- Operating Income
- 117.24
- Net Income Before Taxes
- 111.91
- Net Income
- 94.59
- Diluted Normalized EPS
- 72.3
- Period
- 2020
- Total Assets
- 1107.21
- Total Liabilities
- 676.17
- Total Equity
- 431.04
- Tangible Book Valueper Share Common Eq
- 393.13
- Period
- 2020
- Cashfrom Operating Activities
- 85.23
- Cashfrom Investing Activities
- -267.82
- Cashfrom Financing Activities
- 112.78
- Net Changein Cash
- -69.81
- Period
- 2019
- Total Revenue
- 628.39
- Selling/ General/ Admin Expenses Total
- 290.55
- Depreciation/ Amortization
- 35.53
- Other Operating Expenses Total
- 5.99
- Total Operating Expense
- 531.61
- Operating Income
- 96.78
- Net Income Before Taxes
- 92.84
- Net Income
- 60.14
- Diluted Normalized EPS
- 54.95
- Period
- 2019
- Total Assets
- 849.62
- Total Liabilities
- 506.37
- Total Equity
- 343.24
- Tangible Book Valueper Share Common Eq
- 312.89
- Period
- 2019
- Cashfrom Operating Activities
- 44.51
- Cashfrom Investing Activities
- -270.26
- Cashfrom Financing Activities
- 160.07
- Net Changein Cash
- -65.68
- Period
- 2024-12-31
- Total Revenue
- 355.04
- Selling/ General/ Admin Expenses Total
- 112.57
- Depreciation/ Amortization
- 24.62
- Other Operating Expenses Total
- 45.51
- Total Operating Expense
- 276.76
- Operating Income
- 78.28
- Net Income Before Taxes
- 75.13
- Net Income
- 57.8
- Diluted Normalized EPS
- 52.83
- Period
- 2024-12-31
- Period
- 2024-12-31
- Period
- 2024-09-30
- Total Revenue
- 344
- Selling/ General/ Admin Expenses Total
- 110.33
- Depreciation/ Amortization
- 24.39
- Other Operating Expenses Total
- 43.48
- Total Operating Expense
- 272.88
- Operating Income
- 71.11
- Net Income Before Taxes
- 67.4
- Net Income
- 50.69
- Diluted Normalized EPS
- 46.32
- Period
- 2024-09-30
- Total Assets
- 1645.05
- Total Liabilities
- 671.5
- Total Equity
- 973.55
- Tangible Book Valueper Share Common Eq
- 887.3
- Period
- 2024-09-30
- Cashfrom Operating Activities
- -20.4
- Cashfrom Investing Activities
- -187.36
- Cashfrom Financing Activities
- 84.67
- Net Changein Cash
- -123.09
- Period
- 2024-06-30
- Total Revenue
- 315.11
- Selling/ General/ Admin Expenses Total
- 104.66
- Depreciation/ Amortization
- 24.06
- Other Operating Expenses Total
- 38.87
- Total Operating Expense
- 252.91
- Operating Income
- 62.2
- Net Income Before Taxes
- 60.71
- Net Income
- 45.75
- Diluted Normalized EPS
- 41.81
- Period
- 2024-06-30
- Period
- 2024-06-30
- Period
- 2024-03-31
- Total Revenue
- 321.11
- Selling/ General/ Admin Expenses Total
- 144.41
- Depreciation/ Amortization
- 23.52
- Total Operating Expense
- 252.6
- Operating Income
- 68.52
- Net Income Before Taxes
- 66.91
- Net Income
- 52.18
- Diluted Normalized EPS
- 47.92
- Period
- 2024-03-31
- Total Assets
- 1438.23
- Total Liabilities
- 549.7
- Total Equity
- 888.54
- Tangible Book Valueper Share Common Eq
- 810.67
- Period
- 2024-03-31
- Cashfrom Operating Activities
- 192.68
- Cashfrom Investing Activities
- -138.17
- Cashfrom Financing Activities
- -243.49
- Net Changein Cash
- -188.99
- Period
- 2023-12-31
- Total Revenue
- 321.11
- Selling/ General/ Admin Expenses Total
- 100.95
- Depreciation/ Amortization
- 23.35
- Other Operating Expenses Total
- 39.94
- Total Operating Expense
- 248.12
- Operating Income
- 72.99
- Net Income Before Taxes
- 70.51
- Net Income
- 53.1
- Diluted Normalized EPS
- 48.52
- Period
- 2023-12-31
- Period
- 2023-12-31
Forecast
Income Sheet (In Cr)
Net Income Vs Revenue
Returns Metrics (In Cr)
ROA Vs ROE
Forecast
Balance Sheet
Asset vs Liability
Forecast
Cash Flow
Operating vs Investing
Kovai Medical Cente And Hospital Technical
Moving Average
SMA
- 5 Day5856.02
- 10 Day5735.16
- 20 Day5630.24
- 50 Day5473.41
- 100 Day5664.88
- 300 Day5482.79
Kovai Medical Cente And Hospital Peers
- Price
- Ratio
- Name
- Latest Price
- Change
- % Change
- 52W High
- 52W Low
- Mkt. Cap
- Metropolis Healthcare
- 1639.95
- -19.15
- -1.15
- 2306.85
- 1383.7
- 8414.74
- Healthcare Global Enterprises
- 597.65
- -8.1
- -1.34
- 636.8
- 310.1
- 8380.93
- Kovai Medical Cente And Hospital
- 5843
- -17.8
- -0.3
- 6400
- 3922.05
- 6446.33
- Thyrocare Technologies
- 963.05
- -15.9
- -1.62
- 1053.05
- 570.75
- 5102.74
- Indraprastha Medical Corp
- 416.9
- -2.55
- -0.61
- 571.95
- 212.25
- 3832.94
- Name
- P/E (X)
- P/B (X)
- ROE %
- OPM
- Metropolis Healthcare
- 58.96
- 6.46
- 17.66
- 13.79
- Healthcare Global Enterprises
- 185.28
- 10.19
- -4.88
- -3.5
- Kovai Medical Cente And Hospital
- 34.9
- 7.07
- 19.28
- 12.23
- Thyrocare Technologies
- 55.81
- 9.24
- 20.87
- 17.91
- Indraprastha Medical Corp
- 30.66
- 8.01
- 19.59
- 6.73
Kovai Medical Cente And Hospital Shareholding
Shareholding Pattern
Shareholding Trend
Shareholding(%) v/s Date
Corporate Actions
- Board Meeting
- AGM
- Dividends
- Bonus
- Split
- Rights
- Meeting Date
- Purpose
- 28-May-25
- Audited Results & Final Dividend
- 07-Feb-25
- Quarterly Results
- 08-Nov-24
- Quarterly Results
- 09-Aug-24
- Quarterly Results
- 29-May-24
- Audited Results & Final Dividend
- 09-Feb-24
- Quarterly Results
- 10-Nov-23
- Quarterly Results
- 11-Aug-23
- Quarterly Results
- 29-May-23
- Audited Results & Final Dividend
- 10-Feb-23
- Quarterly Results
- Meeting Date
- Announced on
- Purpose
- 21-Oct-24
- 18-Sept-24
- POM
- 14-Aug-24
- 30-May-24
- AGM
- 08-Jan-24
- 05-Dec-23
- POM
- 25-Aug-23
- 30-May-23
- AGM
- 16-Sept-21
- 03-Jun-21
- AGM
- 29-Jul-21
- 22-Jun-21
- POM
- Announced on
- Record Date
- Ex-Dividend
- Dividend Value
- 29-May-24
- -
- 01-Aug-24
- 10
- 29-May-23
- 11-Aug-23
- 11-Aug-23
- 5
- 30-May-23
- 11-Aug-23
- 11-Aug-23
- 5
- 27-May-22
- -
- 25-Aug-22
- 3
- 28-May-22
- -
- 25-Aug-22
- 3
- 03-Jun-21
- -
- 02-Sept-21
- 3


